Response to Letter to the Editor DOI
Lisa A. Ostrin,

Alexander Schill

Ophthalmic and Physiological Optics, Journal Year: 2024, Volume and Issue: 44(3), P. 674 - 677

Published: March 1, 2024

Language: Английский

Interventions for myopia control in children: a living systematic review and network meta-analysis DOI
John G Lawrenson, Byki Huntjens, Gianni Virgili

et al.

Cochrane library, Journal Year: 2025, Volume and Issue: 2025(2)

Published: Feb. 13, 2025

Language: Английский

Citations

1

Myopia Control: Are We Ready for an Evidence Based Approach? DOI Creative Commons
Leila Sara Eppenberger, Andrzej Grzybowski, Leopold Schmetterer

et al.

Ophthalmology and Therapy, Journal Year: 2024, Volume and Issue: 13(6), P. 1453 - 1477

Published: May 7, 2024

Myopia and its vision-threatening complications present a significant public health problem. This review aims to provide an updated overview of the multitude known emerging interventions control myopia, including their potential effect, safety, costs. A systematic literature search three databases was conducted. Interventions were grouped into four categories: environmental/behavioral (outdoor time, near work), pharmacological (e.g., atropine), optical (spectacles contact lenses), novel approaches such as red-light (RLRL) therapies. Review articles original on randomized controlled trials (RCT) selected. From initial 3224 retrieved records, 18 reviews 41 reporting results from RCTs included. While there is more evidence supporting efficacy low-dose atropine certain myopia-controlling lenses in slowing myopia progression, about newer interventions, spectacle defocus incorporated multiple segments highly aspheric lenslets) limited. Behavioral i.e., increased outdoor seem effective for preventing onset if implemented successfully schools homes. environmental spectacles are regarded generally safe, lenses, RLRL may be associated with adverse effects. All except behavioral change, tied moderate high expenditures. Our suggests that recommended prescribed basis accessibility clinical practice patterns, which vary widely around world. Clinical indicate short- medium-term reducing progression various but none have demonstrated long-term effectiveness adulthood. There unmet need unified consensus strategies balance risk these methods personalized management.

Language: Английский

Citations

8

Low-level red-light therapy for myopia control in children: A systematic review and meta-analysis DOI Creative Commons
Dillan Cunha Amaral, Sávio Batista, Edson dos Santos-Neto

et al.

Clinics, Journal Year: 2024, Volume and Issue: 79, P. 100375 - 100375

Published: Jan. 1, 2024

Low-Level Red-Light (LLRL) Therapy is a safe and natural way to promote healing reduce inflammation in the body. When it comes treating myopia children, LLRL therapy recent, its efficacy safety still are not clear.

Language: Английский

Citations

7

Red light therapy for myopia: Merits, risks and questions DOI
Frank Schaeffel, Christine F. Wildsoet

Ophthalmic and Physiological Optics, Journal Year: 2024, Volume and Issue: 44(5), P. 801 - 807

Published: April 2, 2024

The authors declare no conflicts of interest.

Language: Английский

Citations

6

High myopia: Reviews of myopia control strategies and myopia complications DOI Creative Commons
Rakhee Shah, Natalia Vlasak, Bruce J. W. Evans

et al.

Ophthalmic and Physiological Optics, Journal Year: 2024, Volume and Issue: 44(6), P. 1248 - 1260

Published: July 31, 2024

Abstract Background Myopia and especially high myopia are recognised as major public health concerns. Although the prevalence of in young children is low, 10–20% school Asia have myopia, with many still progressing, one three patients develop visual impairment age. Most participants control studies low moderate myopia; relatively little known about myopia. Method Literature searches were undertaken MEDLINE EMBASE to identify publications English, investigating (Aim 1) efficacy strategies (environmental, pharmacological optical) (≤−6.00 D) 2) complications using keywords. Outcomes included change spherical equivalent refractive error (SE) and/or axial length (AL) evaluate progression Results Aim 1: Twelve identified that reported optical (none on environmental) interventions AL SE for control. A statistically significant reduction myopes was 1% 0.5% atropine. Defocus Incorporated Multiple Segment spectacle lenses had lower slowing compared Ortho‐K equally effective reducing 2: Myopic an increased risk myopic macular degeneration, retinal detachment, cataract glaucoma, increasing level Conclusions High has effects quality life, pathological vision impairment. Young children, excluding those some syndromic associations, who fast progressing require early intervention close monitoring. Further research highly patients, both independently through combination treatments, necessary.

Language: Английский

Citations

6

Photobiomodulation use in ophthalmology – an overview of translational research from bench to bedside DOI Creative Commons
Krisztina Valter, Stephanie E. Tedford, Janis T. Eells

et al.

Frontiers in Ophthalmology, Journal Year: 2024, Volume and Issue: 4

Published: Aug. 15, 2024

Photobiomodulation (PBM) refers to the process in which wavelengths of light are absorbed by intracellular photoacceptors, resulting activation signaling pathways that culminate biological changes within cell. PBM is result low-intensity light-induced reactions cell contrast thermal photoablation produced high-intensity lasers. has been effectively used clinic enhance wound healing and mitigate pain inflammation musculoskeletal conditions, sports injury, dental applications for many decades. In past 20 years, experimental evidence shown benefit increasing numbers retinal ophthalmic conditions. More recently, preclinical findings ocular models have translated with promising results. This review discusses clinical effects ophthalmology provides recommendations use management

Language: Английский

Citations

6

A myopia epidemic is sweeping the globe. Here’s how to stop it DOI Creative Commons

Elie Dolgin

Nature, Journal Year: 2024, Volume and Issue: 629(8014), P. 989 - 991

Published: May 29, 2024

Time spent outdoors is the best defence against rising rates of short-sightedness, but scientists are searching for other ways to reverse troubling trend.

Language: Английский

Citations

5

Effects of short‐term exposure to red or near‐infrared light on axial length in young human subjects DOI Creative Commons
Barbara Świątczak, Frank Schaeffel

Ophthalmic and Physiological Optics, Journal Year: 2024, Volume and Issue: 44(5), P. 954 - 962

Published: April 1, 2024

Abstract Purpose To determine whether visible light is needed to elicit axial eye shortening by exposure long wavelength light. Methods Incoherent narrow‐band red (620 ± 10 nm) or near‐infrared (NIR, 875 30 was generated an array of light‐emitting diodes (LEDs) and projected monocularly in 17 myopic 13 non‐myopic subjects for min. The fellow occluded. Light sources were positioned 50 cm from the a dark room. Axial length (AL) measured before after using low‐coherence interferometry. Results Non‐myopic responded with significant shortening, while NIR induced minor elongation (−13.3 17.3 μm vs. +6.5 11.6 μm, respectively, p = 0.005). Only 41% decrease AL changes therefore, on average, not significantly different those observed (+0.2 12.1 +1.1 11.2 0.83). Interestingly, there correlation between refractive error eyes ( r (15) −0.52, 0.03) (11) 0.62, 0.02), more increasing error. Conclusions at 620 nm 77% eyes. did induce any either group, suggesting that beneficial effect laser therapy myopia progression requires stimulation simply thermal energy.

Language: Английский

Citations

4

Axial Shortening Effects of Repeated Low-level Red-light Therapy in Children with High Myopia: A Multicenter Randomized Controlled Trial DOI Creative Commons
Guihua Liu,

Lin Liu,

Rong Hua

et al.

American Journal of Ophthalmology, Journal Year: 2024, Volume and Issue: 270, P. 203 - 215

Published: Oct. 16, 2024

To evaluate the effectiveness and safety of repeated low-level red-light (RLRL) in delaying progression high myopes with -6.00 diopters (D) or worse. Multicenter, randomized, parallel-group, single-blind clinical trial. A total 202 myopic children aged 7 to 12 years cycloplegia spherical equivalent (SE) refraction ≤-6.00 D, astigmatism less than 2.50 anisometropia 1.50 D were enrolled from March 2022 December 2022. Follow-up was completed 2023. Eligible participants randomly allocated intervention (RLRL + single vision spectacle) control group (single spectacle). The RLRL treatment administered every day for 3 minutes, twice a day, an interval at least 4 hours. primary outcome change axial length (AL) months compared baseline. Secondary outcomes included changes SE, choroidal thickness (ChT), retinal (RT) different circle sectors. Outcomes analyzed by means intention-to-treat per-protocol methods. After treatment, AL SE -0.11 ± 0.25 mm 0.18 0.63 0.32 0.09 -0.80 0.42 group, respectively. Axial shortening >0.05 59% 0% months. ChT RT center analyzed. In thickened all sectors increased parafoveal perifoveal circles. only significantly thinner multivariate linear regression model revealed significant correlations between central foveal 1 month No fundus structure changes, afterimage exceeding 6 best-corrected visual acuity decrease reported. could effectively shorten inhibit myopia patients is sustained over treatment. These observed appeared be associated increases RT.

Language: Английский

Citations

4

Controversies in Myopia Control Treatment: What Does it Mean for Future Research? DOI
Carla Lança, Michael X. Repka, Andrzej Grzybowski

et al.

American Journal of Ophthalmology, Journal Year: 2025, Volume and Issue: unknown

Published: Jan. 1, 2025

Language: Английский

Citations

0